Chugai Reports the NDA Submission of Crovalimab to the MHLW for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Japan
June 14, 2023
Chugai Receives the MHLW Approval for the Additional Indication of Polivy (polatuzumab vedotin) to Treat Diffuse Large B-cell Lymp...
August 24, 2022
Chugai Entered into a License Agreement with Noile-Immune Biotech for PRIME CAR-T Technology
August 23, 2022
Chugai and Towa’s Edirol Receive the MHLW Approval for the Treatment of Osteoporosis
August 17, 2022
Chugai’s Herceptin Receives the MHLW’s Approval for the Treatment of Advanced or Recurrent HER2-Positive Salivary Gland Cancer
November 26, 2021
PharmaShots Weekly Snapshots (July 05 - 09, 2021)
July 9, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.